β-Adrenoceptor blockade modulates fusiform gyrus activity to black versus white faces

Psychopharmacology (Berl). 2015 Aug;232(16):2951-8. doi: 10.1007/s00213-015-3929-7. Epub 2015 Apr 22.

Abstract

Introduction: The beta-adrenoceptor antagonist propranolol is known to reduce peripheral and central activity of noradrenaline. A recent study found that intervention with propranolol diminished negative implicit racial bias.

Materials and method: The current study used functional magnetic resonance imaging (fMRI) in order to determine the neural correlates of this effect. Healthy volunteers (N = 40) of white ethnic origin received a single oral dose (40 mg) of propranolol, in a randomised, double-blind, parallel group, placebo-controlled design, before viewing unfamiliar faces of same and other race.

Results and discussion: We found significantly reduced activity in the fusiform gyrus and thalamus following propranolol to out-group faces only. Additionally, propranolol lowered the implicit attitude score, without affecting explicit prejudice measure.

Conclusion: These findings suggest that noradrenaline pathways might modulate racial bias by acting on the processing of categorisation in the fusiform gyrus.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic beta-Antagonists / pharmacology*
  • Attitude
  • Black or African American
  • Double-Blind Method
  • Face*
  • Female
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Photic Stimulation
  • Prejudice*
  • Propranolol / pharmacology*
  • Temporal Lobe / drug effects*
  • Temporal Lobe / physiology
  • White People
  • Young Adult

Substances

  • Adrenergic beta-Antagonists
  • Propranolol